216 related articles for article (PubMed ID: 25312992)
1. The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis.
Druyts E; Eapen S; Wu P; Thorlund K
Syst Rev; 2014 Oct; 3():116. PubMed ID: 25312992
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review.
Druyts E; Zoratti MJ; Toor K; Wu P; Kanji S; Rabheru K; Mills EJ; Thorlund K
BMC Pediatr; 2016 Nov; 16(1):181. PubMed ID: 27825323
[TBL] [Abstract][Full Text] [Related]
3. Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.
Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):191-202. PubMed ID: 28219485
[TBL] [Abstract][Full Text] [Related]
4. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.
Kinon BJ; Ahl J; Liu-Seifert H; Maguire GA
Psychoneuroendocrinology; 2006 Jun; 31(5):577-88. PubMed ID: 16488084
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.
Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
BMJ Open; 2014 Oct; 4(10):e005708. PubMed ID: 25304189
[TBL] [Abstract][Full Text] [Related]
6. [Endocrine side effects among psychiatric patients treated with antipsychotics].
Kovács L; Kovács G
Neuropsychopharmacol Hung; 2006 Jun; 8(2):61-6. PubMed ID: 17073213
[TBL] [Abstract][Full Text] [Related]
7. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
8. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA
J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665
[TBL] [Abstract][Full Text] [Related]
9. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.
Pringsheim T; Lam D; Ching H; Patten S
Drug Saf; 2011 Aug; 34(8):651-68. PubMed ID: 21751826
[TBL] [Abstract][Full Text] [Related]
11. Use of second-generation antipsychotics in autism spectrum disorder: a systematic review and meta-analysis protocol.
Lopes LPN; de Oliveira JC; Bergamaschi CC; Fulone I; Lima EDC; Abe FC; Mazzei LG; Figueiró MF; Lopes LC
BMJ Open; 2023 Jun; 13(6):e069114. PubMed ID: 37339843
[TBL] [Abstract][Full Text] [Related]
12. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
[TBL] [Abstract][Full Text] [Related]
13. Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis.
Balijepalli C; Druyts E; Zoratti MJ; Wu P; Kanji S; Rabheru K; Yan K; Thorlund K
Schizophr Res Treatment; 2018; 2018():1543034. PubMed ID: 29805808
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole for schizophrenia.
El-Sayeh HG; Morganti C
Cochrane Database Syst Rev; 2006 Apr; (2):CD004578. PubMed ID: 16625607
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
16. Hormonal side effects in women: typical versus atypical antipsychotic treatment.
Dickson RA; Seeman MV; Corenblum B
J Clin Psychiatry; 2000; 61 Suppl 3():10-5. PubMed ID: 10724128
[TBL] [Abstract][Full Text] [Related]
17. Prolactin levels and sexual adverse effects in patients with schizophrenia during antipsychotic treatment.
Rettenbacher MA; Hofer A; Ebenbichler C; Baumgartner S; Edlinger M; Engl J; Kaser S; Kemmler G; Malik P; Tschoner A; Fleischhacker WW
J Clin Psychopharmacol; 2010 Dec; 30(6):711-5. PubMed ID: 21105287
[TBL] [Abstract][Full Text] [Related]
18. [Reproductive dysfunctions in female patients during therapy with atypical antipsychotics].
Gorobets LN; Ermolaeva LG; Litvinov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(8):35-41. PubMed ID: 16972595
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
Roke Y; van Harten PN; Boot AM; Buitelaar JK
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
Leucht S; Cipriani A; Spineli L; Mavridis D; Orey D; Richter F; Samara M; Barbui C; Engel RR; Geddes JR; Kissling W; Stapf MP; Lässig B; Salanti G; Davis JM
Lancet; 2013 Sep; 382(9896):951-62. PubMed ID: 23810019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
